Skip to main content
. 2017 Jan 17;13(3):1109–1116. doi: 10.3892/etm.2017.4051

Table III.

Incidence of AEs.

Variable No. of patients (%) SS: n=197
Total AEs 44 (22.3)
  Study product-related AEs 6 (3.1)
  Severe AEs 2 (1.0)
  AEs leading to discontinuation 3 (1.5)
Study product-related AEs by type
  Amaurosis 1 (0.5)
  Dizziness 3 (1.5)
  Headache 1 (0.5)
  Hypotension 1 (0.5)
  Pruritis 1 (0.5)
  Mucosal and skin rash 1 (0.5)
  Rash 1 (0.5)

SS, safety set; AE, adverse effect.